US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 15.860
- 0.0000.00%
Trading May 23 14:34 ET
407.97MMarket Cap-122945P/E (TTM)
15.970High15.628Low9.04KVolume15.700Open15.860Pre Close142.56KTurnover0.12%Turnover Ratio1441.82P/E (Static)25.72MShares16.09052wk High-5.39P/B117.74MFloat Cap13.27052wk Low--Dividend TTM7.42MShs Float16.090Historical High--Div YieldTTM2.16%Amplitude13.270Historical Low15.765Avg Price1Lot Size
About Contineum Therapeutics Company
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
Company Profile
SymbolCTNM
Company NameContineum Therapeutics
Listing DateApr 5, 2024
Issue Price16.00
Founded2017
CEOMr. Carmine Stengone
MarketNASDAQ
Employees31
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10578 Science Center Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-333-5280
Websitehttp://www.contineum-tx.com
Company Executives
- Name
- Position
- Salary
- Carmine Stengone
- Chief Executive Officer, President and Chairman of the Board
- 2.32M
- Stephen L. Huhn, M.D.
- Chief Medical Officer and Senior Vice President, Clinical Development
- --
- Daniel S. Lorrain, PhD
- Chief Science Officer
- 1.79M
- Peter T. Slover
- Chief Financial Officer and Principal Accounting Officer
- 1.03M
- Evert B. Schimmelpennink
- Independent Director
- 23.82K
- Dr. Todd C. Brady, M.D.,PhD
- Independent Director
- --
- Troy A. Ignelzi
- Independent Director
- --
- Olivia C. Ware, M.B.A.
- Independent Director
- --
- Lori Lyons-Williams
- Independent Director
- 25.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
